
Release date: 2024-08-22 16:49:51 Article From: Lucius Laos Recommended: 241
Anamorelin is a ghrelin receptor agonist launched in Japan that brings a new treatment option to cancer cachexia patients by increasing appetite and weight.
When using Anamorelin, it is important to be aware of possible interactions with other drugs.
Drugs such as erythromycin, diltiazem, and imatinib may inhibit CYP3A4 and hinder the metabolism of Anamorelin, leading to elevated blood levels and increasing the risk of side effects.
The ingredients in grapefruit juice inhibit CYP3A4, affect the metabolism of anamolin, may lead to an increase in drug concentrations and increased side effects, and should be avoided at the same time.
When using Anamorelin, it is necessary to pay special attention to the interaction between these drugs and foods to avoid unnecessary side effects. Next, we will explore the therapeutic effects of anamorin and see how it performs in improving the patient's condition.
The therapeutic effect of Anamorelin is mainly reflected in the following aspects:
In clinical studies in Japan, anamolin showed significant therapeutic effects in patients with non-small cell lung cancer. A total of 173 patients participated in the study and took 100 mg of anamarin daily on an empty stomach for 12 weeks.
The study found that patients experienced a significant increase in lean body mass during the treatment period, with highly statistically significant results, showing that Anamorelin performed well in improving weight loss and muscle burn.
Anamorelin has shown excellent performance in improving weight and muscle burn in patients with non-small cell lung cancer. It is still necessary to pay attention to possible adverse reactions during use.
Anamorelin may cause some adverse effects during treatment. Common adverse effects include the following:
In people with diabetes, Anamorelin may make blood sugar control more difficult, leading to worsening diabetes symptoms. Blood glucose should be monitored closely and the need to adjust the diabetes management regimen should be discussed with the doctor.
Anamorelin may affect the liver, leading to elevated levels of liver enzymes or abnormal liver function. It is advisable to have regular liver function tests, and if any abnormalities are found, you should inform your doctor in time.
When using Anamorelin, it is essential to monitor your physical condition in a timely manner. If there is any abnormality, it is recommended to communicate with the doctor immediately to ensure the smooth progress of the treatment.
[Warm tips] When using Anamorelin, please monitor your blood sugar and liver function regularly, and contact your doctor in time if you find any abnormalities. If you experience any discomfort during the medication, it is important to seek medical advice as soon as possible.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1592025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3992024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1532025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1712025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1532025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1872025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1672025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1622025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: